In the Editorial titled “Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis,” published online October 12, 2015, in JAMA Neurology,1 there was a reference error in the second sentence of the second paragraph. The second sentence should read as follows: “Arnon and colleagues2,3 assessed the effects of synthetic polypeptides on the MS model of experimental autoimmune encephalomyelitis.” This article was corrected online.
Error in Text. JAMA Neurol. 2015;72(12):1537. doi:10.1001/jamaneurol.2015.4174